Income Taxes
On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted into U.S. tax law. OBBBA includes a broad range of tax reform provisions, such as the permanent extension of certain expiring provisions of the 2017 Tax Cuts and Jobs Act and modifications to the international tax framework. The enactment of OBBBA did not have a material impact on the Company’s results of operations, financial position, or cash flows for the year.
For financial reporting purposes, income (loss) before income taxes includes the following components (in thousands):
Years Ended December 31,
202520242023
United States$6,302 $32,443 $(8,342)
Foreign300,368 217,966 155,969 
Total$306,670 $250,409 $147,627 

The expense (benefit) for income taxes consists of the following (in thousands):
Years Ended December 31,
202520242023
Federal
Current$944 $10,062 $(3,490)
Deferred(348)(12,919)(6,306)
Total596 (2,857)(9,796)
State
Current1,407 3,069 (2,327)
Deferred749 (2,390)797 
Total2,156 679 (1,530)
Foreign
Current76,718 47,290 36,020 
Deferred542 2,179 1,424 
Total77,260 49,469 37,444 
Total$80,012 $47,291 $26,118 
Differences between the income tax expense computed at the statutory federal income tax rate and per the consolidated statements of operations, after adoption of ASU 2023-09, are summarized as follows (in thousands):

Year Ended December 31,
2025
AmountPercent
U.S. federal statutory tax rate$64,401 21.00 %
State and local income taxes, net of federal income tax effect (1)1,712 0.56 
Foreign tax effects
Ireland
Statutory tax rate difference between Ireland and United States(17,010)(5.55)
Withholding tax on royalties and service income19,190 6.26 
Other1,088 0.35 
India
Withholding tax on dividends5,926 1.93 
Other(2,218)(0.72)
Other foreign jurisdictions7,449 2.43 
Effect of changes in tax laws or rates enacted in the current period— — 
Effect of cross-border tax laws
Other529 0.17 
Tax credits
Other(3,059)(1.00)
Changes in valuation allowances1,476 0.48 
Nontaxable or nondeductible items
Other855 0.28 
Changes in unrecognized tax benefits(627)(0.20)
Other300 0.10 
Effective tax rate$80,012 26.09 %

(1)The states that contribute to the majority (greater than 50 percent) of the tax effect include California, Maryland, and New Jersey.

As previously disclosed for the years ended December 31, 2024 and 2023, prior to the adoption of ASU 2023-09, the following is a reconciliation of differences between the income tax expense computed at the statutory federal income tax rate and per the consolidated statements of operations are summarized as follows (in thousands):

Years Ended December 31,
20242023
Tax expense at federal rate of 21%$52,586 $31,002 
State income taxes, net of federal benefit1,558 1,744 
Change in valuation allowance342 1,588 
Foreign tax rate differential(8,081)(7,658)
Unrecognized tax benefit increase (decrease)223 (5,726)
Tax effect of foreign operations5,911 10,350 
Tax benefit of research & development(5,492)(5,104)
Performance-based compensation(424)3,004 
Tax effect of divestiture— (2,900)
Other668 (182)
Income tax provision$47,291 $26,118 
The following table presents supplemental cash flow information related to income taxes paid (net of refunds) by jurisdiction for the year ended December 31, (in thousands):

2025
Federal$6,807 
State and local2,888 
Foreign
Ireland57,301 
India9,384 
United Kingdom6,612 
All other foreign7,054 
Total$90,046 

The deferred tax assets and liabilities result from differences in the timing of the recognition of certain income and expense items for tax and financial accounting purposes. The sources of these differences at each balance sheet date are as follows (in thousands):
December 31,
20252024
Deferred income tax assets:
Net operating loss carryforwards$11,586 $13,636 
Tax credits30,623 23,242 
Compensation16,704 16,527 
Deferred revenue9,353 11,273 
Operating lease6,138 6,796 
Capitalized research and development27,096 20,102 
Deferred interest
29,759 27,807 
Other3,072 2,455 
Gross deferred income tax assets134,331 121,838 
Less: valuation allowance(18,215)(13,310)
Net deferred income tax assets$116,116 $108,528 
Deferred income tax liabilities:
Depreciation and amortization$(35,926)$(30,957)
Operating lease right-of-use asset(5,544)(6,079)
Unbilled revenue(10,381)(7,938)
Withholding tax liability(29,655)(30,761)
Total deferred income tax liabilities(81,506)(75,735)
Net deferred income taxes$34,610 $32,793 
Deferred income taxes / liabilities included in the balance sheet are:
Deferred income tax asset – noncurrent$73,124 $72,713 
Deferred income tax liability – noncurrent(38,514)(39,920)
Net deferred income taxes$34,610 $32,793 
In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income, carryback opportunities, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, the Company believes it is more likely than not that it will realize the benefits of these deductible differences, net of the valuation allowances recorded. At December 31, 2025, valuation allowances recorded primarily related to net operating losses, foreign tax credit carryforwards, and future interest deductions.

At December 31, 2025, the Company had domestic federal tax net operating losses (“NOLs”) of $37.6 million, of which $2.9 million may be utilized over an indefinite life, with the remainder beginning to expire in 2027. The Company had deferred tax assets equal to $0.7 million related to domestic state tax NOLs which will begin to expire in 2026. The Company did not have any valuation allowance against the federal tax NOLs but had provided a $0.4 million valuation allowance against the deferred tax asset associated with the state NOLs. The Company had foreign tax NOLs of $11.3 million, of which $11.0 million may be utilized over an indefinite life, with the remainder expiring over the next five years. The Company did not have any valuation allowance against the deferred tax asset associated with the foreign NOLs.

The Company had U.S. foreign tax credit carryforwards at December 31, 2025, of $6.8 million, for which a $4.2 million valuation allowance had been provided. The U.S. foreign tax credits will begin to expire in 2028. The Company had foreign tax credit carryforwards in other foreign jurisdictions at December 31, 2025, of $5.1 million, of which $1.1 million may be utilized over an indefinite life, with the remainder expiring over the next seven years. The Company had provided a $1.7 million valuation allowance against the tax benefit associated with these foreign credits. The Company also had domestic federal general business tax credit carryforwards at December 31, 2025, of $29.8 million, which will begin to expire in 2037 and state general business tax credit carryforwards of $0.5 million, which will begin to expire in 2026.

As of December 31, 2025, deferred taxes for non-United States withholding and other taxes were provided on $74.1 million of unremitted earnings of non-United States subsidiaries that may be remitted to the United States. As of December 31, 2025 and 2024, the Company recorded a deferred tax liability of $5.1 million and $1.0 million, respectively, related to these non-United States earnings that may be remitted.

As of December 31, 2025 and 2024, the Company had a German interest deduction carryforward of $11.2 million and $9.0 million, respectively, for which a full valuation allowance had been provided. The deferred interest deduction has an indefinite life.

As of December 31, 2025 and 2024, the unrecognized tax benefits were $20.3 million and $21.0 million, respectively, of which $8.7 million and $10.7 million, respectively, are included in other noncurrent liabilities in the consolidated balance sheets. Of the total unrecognized tax benefit amounts as of December 31, 2025 and 2024, $19.7 million and $20.4 million, respectively, represent net unrecognized tax benefits that, if recognized, would have a favorable impact on the Company's effective income tax rate.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31 is as follows (in thousands):
202520242023
Balance of unrecognized tax benefits at beginning of year$21,027 $20,889 $26,408 
Increases for tax positions of prior years190 1,159 1,568 
Decreases for tax positions of prior years(1,699)(1,080)(6,560)
Increases for tax positions established for the current period1,989 2,418 3,941 
Decreases for settlements with taxing authorities(299)(141)(532)
Reductions resulting from lapse of applicable statute of limitation(978)(2,190)(4,005)
Adjustment resulting from foreign currency translation78 (28)69 
Balance of unrecognized tax benefits at end of year$20,308 $21,027 $20,889 
The Company files income tax returns in the U.S. federal jurisdiction, various state and local jurisdictions, and many foreign jurisdictions. The United States, Ireland, and the United Kingdom are the main taxing jurisdictions in which the Company operates. The years open for audit vary depending on the tax jurisdiction. In the United States, the Company’s federal tax return for years following 2021 are open for audit. In the foreign jurisdictions, the tax returns open for audit generally vary by jurisdiction between 2017 and 2024.

The Company is being audited by the Canada Revenue Agency for the years ended December 31, 2019 to 2021, and by the Indian tax authority for fiscal years ended March 31, 2021 to 2023. Other foreign subsidiaries could face challenges from various foreign tax authorities. It is not certain that the local authorities will accept the Company’s tax positions. The Company believes its tax positions comply with applicable tax law and intends to vigorously defend its positions. However, differing positions on certain issues could be upheld by tax authorities, which could adversely affect the Company’s financial condition and results of operations.

The Company accrues interest related to uncertain tax positions in interest expense or interest income and recognizes penalties related to uncertain tax positions in other income (expense). As of December 31, 2024, $0.4 million was accrued for the payment of interest and penalties related to income tax liabilities. There was no amount accrued for the payment of interest and penalties related to income tax liabilities as of December 31, 2025. For the years ended December 31, 2025, 2024, and 2023, the total expense (benefit) for interest and penalties recorded in the statements of operations was $(0.4) million, $(0.1) million, and $(0.1) million, respectively.

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2024Feb 27, 2025
2023Feb 29, 2024
2022Mar 1, 2023
2021Feb 24, 2022
2020Feb 25, 2021
2019Feb 27, 2020
2018Mar 1, 2019
2017Feb 27, 2018
2016Mar 1, 2017
2015Feb 26, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.